Bionote USA welcomes 2 new regional sales managers

Frank Pickard (left) and Mat Parker (right).

Bionote USA, manufacturer of veterinary analyzers and biomarker tests, appoints Mat Parker and Frank Pickard as regional sales managers to cover the southeastern and southcentral regions of the United States respectively. Parker and Pickard will represent Bionote’s expanding Vcheck line of in-clinic quantitative analyzers and tests with Bionote distribution partners, as well as directly within their sales regions.

According to a company release, the duo have a combined total of 50 years of medical field experience that they will maximize and use to collaborate with distribution, veterinary practice owners and staff to ensure customer satisfaction while maintaining a critical role in product installations and training.

What’s more, Parker and Pickard will work closely with local veterinary clinics and inform veterinarians and staff about the advantages of Bionote’s recently released Vcheck NT-proBNP test—the first-ever in-clinic, quantitative diagnostic test kit for detecting canine heart disease early.

“Our distributors and veterinary professionals in these regions can really depend on Parker and Pickard. They both demonstrate top-notch follow-through and significant industry expertise that will help align veterinary practices with the best point-of-care solutions from Bionote,” said Randy Knick, president of Bionote USA, in the release.

Bionote’s line of quantitative diagnostic products are available in the US and Canada. Learn more about Bionote USA or place an order by contacting: Mat Parker at matparker@bionote.com (Carolinas, Florida and southern Georgia) or Frank Pickard at frankpickard@bionote.com (Tennessee, Kentucky, Mississippi, Alabama and northern Georgia). You can also contact the company’s sales team through the company website: www.bionote.com.

Reference

Mat Parker and Frank Pickard join Bionote USA as regional sales managers. News release. Bionote USA. November 11, 2021. Accessed November 17, 2021.